Mini-review: new therapeutic options in hypoparathyroidism
- 7 February 2012
- journal article
- review article
- Published by Springer Science and Business Media LLC in Endocrine
- Vol. 41 (3), 410-414
- https://doi.org/10.1007/s12020-012-9618-y
Abstract
Hypoparathyroidism is a disorder characterized by hypocalcemia and low or absent parathyroid hormone (PTH). While standard treatment of hypoparathyroidism consists of oral calcium and vitamin D supplementation, maintaining serum calcium levels can be a challenge, and concerns exist regarding hypercalciuria and ectopic calcifications that can be associated with such treatment. Hypoparathyroidism is the only classic endocrine deficiency disease for which the missing hormone, PTH, is not yet an approved treatment. This mini-review focuses on the use of PTH in the treatment of hypoparathyroidism. There are two available formulations of PTH: teriparatide [human PTH(1-34)] and the full-length molecule, PTH(1-84). Both PTH(1-34) and PTH(1-84) lower supplemental vitamin D requirements and increase markers of bone turnover. Densitometric and histomorphometric studies in some subjects treated with PTH(1-84) demonstrate improvement in abnormal bone-remodeling dynamics and return of bone metabolism toward normal euparathyroid levels. Further detailed examination of skeletal features following therapy with the different treatment regimens and data regarding the effect of PTH on quality of life measures are under active investigation.This publication has 22 references indexed in Scilit:
- CorrigendaJournal of Clinical Endocrinology & Metabolism, 2015
- Hypoparathyroidism in the adult: Epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future researchJournal of Bone and Mineral Research, 2011
- The effect of adding PTH(1–84) to conventional treatment of hypoparathyroidism: A randomized, placebo-controlled studyJournal of Bone and Mineral Research, 2011
- PTH(1–84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidismJournal of Bone and Mineral Research, 2011
- Long-Term Treatment of 12 Children with Chronic Hypoparathyroidism: A Randomized Trial Comparing Synthetic Human Parathyroid Hormone 1-34 versus Calcitriol and CalciumJournal of Clinical Endocrinology & Metabolism, 2010
- Three dimensional cancellous bone structure in hypoparathyroidismBone, 2010
- Therapy of hypoparathyroidism with intact parathyroid hormoneOsteoporosis International, 2010
- Dynamic and Structural Properties of the Skeleton in HypoparathyroidismJournal of Bone and Mineral Research, 2008
- HypoparathyroidismThe New England Journal of Medicine, 2008
- Hypoparathyroidism Counteracts Risk Factors for OsteoporosisThe American Journal of the Medical Sciences, 1995